Risks of Traditional Herbal Medicine Use in Cancer Care in the Middle East
I cover this is some detail in an extensive chapter on complementary and alternative medicine . There is virtually NO SCIENCE worth a plug nickel on almost all herbal medications , not all and some eventually do lead to phased trials and add to our armamentarium. The point is that I made it clear to my patients that if they did not tell me every single potion liniment oil whatever they were letting in or near or on their body They would need to find another Oncologist as I am not a Shaman or medicine man . I did not say if they did not stop. That is where the research and critical thinking by both the patient and I worked together to reach an agreement .If I felt clear more harm which includes the unknown, than good- they found a new home . I had a couple very respectfully decline therapy for nodular lymphoma and another for Hosking’s disease They are both dead due to their disease and I believe aided and abetted by what they put in their bodies. Read the chapter carefully and what I wrote carefully and you will have no problem . I did not say never and I did not say some do not eventually get shown to be of superior aid than what we have
The authors assessed the use of herbal medicine by Middle Eastern patients with cancer, as reported by their oncology health care professionals (HCPs). Herbal products identified by the study HCPs were evaluated for potential negative effects.
Oncology HCPs from 16 Middle Eastern countries received a 17-item questionnaire asking them to list 5 herbal products in use by their patients with cancer. A literature search (PubMed, Micromedex, AltMedDex, and the Natural Medicine Comprehensive Database) was conducted to identify safety-related concerns associated with the products listed.
A total of 339 HCPs completed the study questionnaire (response rate of 80.3%), identifying 44 herbal and 3 nonherbal nutritional supplements. Safety-related concerns were associated with 29 products, including herb-drug interactions with altered pharmacodynamics (15 herbs), direct toxic effects (18 herbs), and increased in vitro response of cancer cells to chemotherapy (7 herbs).
Herbal medicine use, which is prevalent in Middle Eastern countries, has several potentially negative effects that include direct toxic effects, negative interactions with anticancer drugs, and increased chemosensitivity of cancer cells, requiring a reduction in dosedensity. Oncology HCPs working in countries in which herbal medicine use is prevalent need to better understand the implications of this practice. The presence of integrative physicians with training in complementary and traditional medicine can help patients and their HCPs reach an informed decision regarding the safety and effective use of these products.